Global Live Herpes Zoster Vaccine Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Live Herpes Zoster Vaccine Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Live Herpes Zoster Vaccine by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Live Herpes Zoster Vaccine by Country/Region, 2019, 2023 & 2030 2.2 Live Herpes Zoster Vaccine Segment by Type 2.2.1 Single-dose Vaccination 2.2.2 Double-dose Vaccination 2.3 Live Herpes Zoster Vaccine Sales by Type 2.3.1 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) 2.3.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Type (2019-2024) 2.3.3 Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024) 2.4 Live Herpes Zoster Vaccine Segment by Application 2.4.1 Public Health Sector 2.4.2 Hospitals & clinics 2.4.3 Others 2.5 Live Herpes Zoster Vaccine Sales by Application 2.5.1 Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024) 2.5.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Application (2019-2024) 2.5.3 Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Live Herpes Zoster Vaccine Breakdown Data by Company 3.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Company (2019-2024) 3.1.2 Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024) 3.2 Global Live Herpes Zoster Vaccine Annual Revenue by Company (2019-2024) 3.2.1 Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024) 3.2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024) 3.3 Global Live Herpes Zoster Vaccine Sale Price by Company 3.4 Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Live Herpes Zoster Vaccine Product Location Distribution 3.4.2 Players Live Herpes Zoster Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Live Herpes Zoster Vaccine by Geographic Region 4.1 World Historic Live Herpes Zoster Vaccine Market Size by Geographic Region (2019-2024) 4.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Live Herpes Zoster Vaccine Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Live Herpes Zoster Vaccine Market Size by Country/Region (2019-2024) 4.2.1 Global Live Herpes Zoster Vaccine Annual Sales by Country/Region (2019-2024) 4.2.2 Global Live Herpes Zoster Vaccine Annual Revenue by Country/Region (2019-2024) 4.3 Americas Live Herpes Zoster Vaccine Sales Growth 4.4 APAC Live Herpes Zoster Vaccine Sales Growth 4.5 Europe Live Herpes Zoster Vaccine Sales Growth 4.6 Middle East & Africa Live Herpes Zoster Vaccine Sales Growth 5 Americas 5.1 Americas Live Herpes Zoster Vaccine Sales by Country 5.1.1 Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024) 5.1.2 Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024) 5.2 Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024) 5.3 Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Live Herpes Zoster Vaccine Sales by Region 6.1.1 APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024) 6.1.2 APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024) 6.2 APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024) 6.3 APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Live Herpes Zoster Vaccine by Country 7.1.1 Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) 7.1.2 Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) 7.2 Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024) 7.3 Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Live Herpes Zoster Vaccine by Country 8.1.1 Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) 8.1.2 Middle East & Africa Live Herpes Zoster Vaccine Revenue by Country (2019-2024) 8.2 Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024) 8.3 Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine 10.3 Manufacturing Process Analysis of Live Herpes Zoster Vaccine 10.4 Industry Chain Structure of Live Herpes Zoster Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Live Herpes Zoster Vaccine Distributors 11.3 Live Herpes Zoster Vaccine Customer 12 World Forecast Review for Live Herpes Zoster Vaccine by Geographic Region 12.1 Global Live Herpes Zoster Vaccine Market Size Forecast by Region 12.1.1 Global Live Herpes Zoster Vaccine Forecast by Region (2025-2030) 12.1.2 Global Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Live Herpes Zoster Vaccine Forecast by Type (2025-2030) 12.7 Global Live Herpes Zoster Vaccine Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications 13.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 GSK 13.2.1 GSK Company Information 13.2.2 GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications 13.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 GSK Main Business Overview 13.2.5 GSK Latest Developments 13.3 SK 13.3.1 SK Company Information 13.3.2 SK Live Herpes Zoster Vaccine Product Portfolios and Specifications 13.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 SK Main Business Overview 13.3.5 SK Latest Developments 13.4 Changchun BCHT Biotechnology 13.4.1 Changchun BCHT Biotechnology Company Information 13.4.2 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications 13.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Changchun BCHT Biotechnology Main Business Overview 13.4.5 Changchun BCHT Biotechnology Latest Developments 13.5 SIBP CNBG 13.5.1 SIBP CNBG Company Information 13.5.2 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications 13.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 SIBP CNBG Main Business Overview 13.5.5 SIBP CNBG Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Live Herpes Zoster Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Live Herpes Zoster Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Single-dose Vaccination Table 4. Major Players of Double-dose Vaccination Table 5. Global Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose) Table 6. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) Table 7. Global Live Herpes Zoster Vaccine Revenue by Type (2019-2024) & ($ million) Table 8. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024) Table 9. Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024) & (US$/Dose) Table 10. Global Live Herpes Zoster Vaccine Sale by Application (2019-2024) & (K Dose) Table 11. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024) Table 12. Global Live Herpes Zoster Vaccine Revenue by Application (2019-2024) & ($ million) Table 13. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2024) Table 14. Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024) & (US$/Dose) Table 15. Global Live Herpes Zoster Vaccine Sales by Company (2019-2024) & (K Dose) Table 16. Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024) Table 17. Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024) & ($ millions) Table 18. Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024) Table 19. Global Live Herpes Zoster Vaccine Sale Price by Company (2019-2024) & (US$/Dose) Table 20. Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution and Sales Area Table 21. Players Live Herpes Zoster Vaccine Products Offered Table 22. Live Herpes Zoster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Live Herpes Zoster Vaccine Sales by Geographic Region (2019-2024) & (K Dose) Table 26. Global Live Herpes Zoster Vaccine Sales Market Share Geographic Region (2019-2024) Table 27. Global Live Herpes Zoster Vaccine Revenue by Geographic Region (2019-2024) & ($ millions) Table 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region (2019-2024) Table 29. Global Live Herpes Zoster Vaccine Sales by Country/Region (2019-2024) & (K Dose) Table 30. Global Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019-2024) Table 31. Global Live Herpes Zoster Vaccine Revenue by Country/Region (2019-2024) & ($ millions) Table 32. Global Live Herpes Zoster Vaccine Revenue Market Share by Country/Region (2019-2024) Table 33. Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose) Table 34. Americas Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024) Table 35. Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions) Table 36. Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose) Table 37. Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose) Table 38. APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose) Table 39. APAC Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2024) Table 40. APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & ($ millions) Table 41. APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose) Table 42. APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose) Table 43. Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose) Table 44. Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions) Table 45. Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose) Table 46. Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose) Table 47. Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose) Table 48. Middle East & Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024) Table 49. Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose) Table 50. Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose) Table 51. Key Market Drivers & Growth Opportunities of Live Herpes Zoster Vaccine Table 52. Key Market Challenges & Risks of Live Herpes Zoster Vaccine Table 53. Key Industry Trends of Live Herpes Zoster Vaccine Table 54. Live Herpes Zoster Vaccine Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Live Herpes Zoster Vaccine Distributors List Table 57. Live Herpes Zoster Vaccine Customer List Table 58. Global Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose) Table 59. Global Live Herpes Zoster Vaccine Revenue Forecast by Region (2025-2030) & ($ millions) Table 60. Americas Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose) Table 61. Americas Live Herpes Zoster Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 62. APAC Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose) Table 63. APAC Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 64. Europe Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose) Table 65. Europe Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose) Table 67. Middle East & Africa Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 68. Global Live Herpes Zoster Vaccine Sales Forecast by Type (2025-2030) & (K Dose) Table 69. Global Live Herpes Zoster Vaccine Revenue Forecast by Type (2025-2030) & ($ millions) Table 70. Global Live Herpes Zoster Vaccine Sales Forecast by Application (2025-2030) & (K Dose) Table 71. Global Live Herpes Zoster Vaccine Revenue Forecast by Application (2025-2030) & ($ millions) Table 72. Merck Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors Table 73. Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications Table 74. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024) Table 75. Merck Main Business Table 76. Merck Latest Developments Table 77. GSK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors Table 78. GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications Table 79. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024) Table 80. GSK Main Business Table 81. GSK Latest Developments Table 82. SK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors Table 83. SK Live Herpes Zoster Vaccine Product Portfolios and Specifications Table 84. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024) Table 85. SK Main Business Table 86. SK Latest Developments Table 87. Changchun BCHT Biotechnology Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications Table 89. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024) Table 90. Changchun BCHT Biotechnology Main Business Table 91. Changchun BCHT Biotechnology Latest Developments Table 92. SIBP CNBG Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications Table 94. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024) Table 95. SIBP CNBG Main Business Table 96. SIBP CNBG Latest Developments List of Figures Figure 1. Picture of Live Herpes Zoster Vaccine Figure 2. Live Herpes Zoster Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Live Herpes Zoster Vaccine Sales Growth Rate 2019-2030 (K Dose) Figure 7. Global Live Herpes Zoster Vaccine Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Live Herpes Zoster Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2023) Figure 10. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Single-dose Vaccination Figure 12. Product Picture of Double-dose Vaccination Figure 13. Global Live Herpes Zoster Vaccine Sales Market Share by Type in 2023 Figure 14. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024) Figure 15. Live Herpes Zoster Vaccine Consumed in Public Health Sector Figure 16. Global Live Herpes Zoster Vaccine Market: Public Health Sector (2019-2024) & (K Dose) Figure 17. Live Herpes Zoster Vaccine Consumed in Hospitals & clinics Figure 18. Global Live Herpes Zoster Vaccine Market: Hospitals & clinics (2019-2024) & (K Dose) Figure 19. Live Herpes Zoster Vaccine Consumed in Others Figure 20. Global Live Herpes Zoster Vaccine Market: Others (2019-2024) & (K Dose) Figure 21. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2023) Figure 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Application in 2023 Figure 23. Live Herpes Zoster Vaccine Sales by Company in 2023 (K Dose) Figure 24. Global Live Herpes Zoster Vaccine Sales Market Share by Company in 2023 Figure 25. Live Herpes Zoster Vaccine Revenue by Company in 2023 ($ millions) Figure 26. Global Live Herpes Zoster Vaccine Revenue Market Share by Company in 2023 Figure 27. Global Live Herpes Zoster Vaccine Sales Market Share by Geographic Region (2019-2024) Figure 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region in 2023 Figure 29. Americas Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose) Figure 30. Americas Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions) Figure 31. APAC Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose) Figure 32. APAC Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions) Figure 33. Europe Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose) Figure 34. Europe Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions) Figure 35. Middle East & Africa Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose) Figure 36. Middle East & Africa Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions) Figure 37. Americas Live Herpes Zoster Vaccine Sales Market Share by Country in 2023 Figure 38. Americas Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024) Figure 39. Americas Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) Figure 40. Americas Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024) Figure 41. United States Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 42. Canada Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 43. Mexico Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 44. Brazil Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 45. APAC Live Herpes Zoster Vaccine Sales Market Share by Region in 2023 Figure 46. APAC Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2024) Figure 47. APAC Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) Figure 48. APAC Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024) Figure 49. China Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 50. Japan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 51. South Korea Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 52. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 53. India Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 54. Australia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 55. China Taiwan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 56. Europe Live Herpes Zoster Vaccine Sales Market Share by Country in 2023 Figure 57. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024) Figure 58. Europe Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) Figure 59. Europe Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024) Figure 60. Germany Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 61. France Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 62. UK Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 63. Italy Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 64. Russia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 65. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024) Figure 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024) Figure 67. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024) Figure 68. Egypt Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 69. South Africa Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 70. Israel Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 71. Turkey Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 72. GCC Countries Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions) Figure 73. Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine in 2023 Figure 74. Manufacturing Process Analysis of Live Herpes Zoster Vaccine Figure 75. Industry Chain Structure of Live Herpes Zoster Vaccine Figure 76. Channels of Distribution Figure 77. Global Live Herpes Zoster Vaccine Sales Market Forecast by Region (2025-2030) Figure 78. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Region (2025-2030) Figure 79. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Type (2025-2030) Figure 80. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Type (2025-2030) Figure 81. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Application (2025-2030) Figure 82. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
'Merck'|||'GSK'|||'SK'|||'Changchun BCHT Biotechnology'|||'SIBP CNBG'